Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02935 |
| Species: | Mus musculus |
| Position : | chr16:25400000-25900000 |
| Year: | 2020 |
| Title: | ERG orchestrates chromatin interactions to drive prostate cell fate reprogramming |
| Genome Build: | mm10 |
| Enhancer Type: | Super-enhancer |
| Condition: | Disease |
| Disease Name: | prostate cancer |
| PMID: | 32701507 |
| MONDO: | MONDO:0008315 |
| Tissue: | Prostate |
| Tissue Ontology ID: | UBERON:0002367 |
| Cell Source: | Mouse Prostate Epithelial Organoids |
| CVCL ID: | |
| Cell Type: | mouse prostate epithelial organoid cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Chromatin interaction assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, RNA-seq, Hi-C, ATAC-seq |
| Low Throughput Method: | CRISPR Knockout, qRT-PCR, Western blot, Immunofluorescence |
| Target gene : | Trp63 |
| TF name : |
| Regulatory State : | Silenced |
| GeneName | Pathway Name | Source | Gene Number |
|---|